GlassScriptPhysician profile
Vijay M Haryani
NPI 1487679205
$412,806.49
in general payments reported to CMS, 2019-2025
53 companies · $1,727 in 2025
The $1,727 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57K · 2020: $28K · 2021: $55K · 2022: $195K · 2023: $37K · 2024: $39K · 2025: $1,727.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53K · Food and Beverage: $12K · Travel and Lodging: $12K · Education: $98.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53,195.00 |
| Food and Beverage | $11,990.07 |
| Travel and Lodging | $11,570.56 |
| Education | $98.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $102,814.77 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $102,788.97 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68,308.47 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $36,931.70 | 2019-2025 | Lokelma, Farxiga, Wainua |
| Bayer Healthcare Pharmaceuticals INC. | $22,687.52 | 2019-2025 | |
| Lilly USA, LLC | $16,792.49 | 2020-2024 | Jardiance |
| United Therapeutics Corporation | $13,292.34 | 2019-2024 | Tyvaso |
| Merck Sharp & Dohme LLC | $12,234.45 | 2021-2025 | Verquvo, Winrevair |
| Pfizer INC. | $10,964.56 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $10,572.73 | 2019-2025 | Eliquis, Camzyos |
| Abbott Laboratories | $3,662.47 | 2019-2025 | Cardiomems, Jeti, Mitraclip |
| Novartis Pharmaceuticals Corporation | $1,786.01 | 2019-2025 | |
| Penumbra, INC. | $1,533.74 | 2023 | Indigo System, Penumbra System |
| Medtronic, INC. | $1,165.46 | 2021-2025 | Corevalve Evolut R, Hawkone, Symplicity G3 |
| Amgen INC. | $924.12 | 2019-2025 | Repatha, Repatha |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $836.05 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $638.38 | 2019-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $622.36 | 2019-2025 | Uptravi, Opsumit |
| Alnylam Pharmaceuticals INC. | $621.83 | 2019-2025 | Onpattro, Amvuttra |
| Esperion Therapeutics, INC. | $449.04 | 2020-2025 | Nexletol |
| Endologix LLC | $354.16 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $216.22 | 2019-2025 | Evkeeza, Praluent |
| Abiomed | $212.57 | 2020-2021 | |
| Bridgebio Pharma, INC. | $190.47 | 2025 | Attruby |
| Impulse Dynamics (USA) INC. | $177.07 | 2023 | Optimizer |
| Vifor Pharma, INC. | $175.05 | 2019-2023 | Veltassa |
| Philips North America LLC | $162.96 | 2019-2023 | |
| Medtronic Vascular, INC. | $162.84 | 2019-2020 | |
| Boston Scientific Corporation | $161.94 | 2021-2023 | Mamba |
| Bard Peripheral Vascular, INC. | $141.82 | 2023 | Lifestream, Venovo, Atlas |
| Glaxosmithkline, LLC. | $124.72 | 2023 | Arexvy |
| Amarin Pharma, INC. | $120.96 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.91 | 2023 | Trulance |
| Scpharmaceuticals INC. | $109.73 | 2023-2024 | |
| Lexicon Pharmaceuticals, INC. | $93.43 | 2023-2024 | Inpefa |
| Chiesi USA, INC. | $90.58 | 2020-2024 | Cleviprex, Kengreal |
| Cook Medical LLC | $85.11 | 2019-2024 | Zenith Spiral-Z |
| Kiniksa Pharmaceuticals International, Plc | $82.45 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $70.77 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $54.87 | 2019-2021 | |
| Nuwellis, INC. | $26.50 | 2024 | Aquadex Smartflow Console |
| Terumo Medical Corporation | $25.82 | 2019 | |
| Ionis Pharmaceuticals, INC. | $25.56 | 2025 | Tryngolza |
| Veryan Medical Incorporated | $24.84 | 2022 | |
| Cvrx, INC. | $24.35 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $24.19 | 2023 | Arcalyst |
| Biotronik INC. | $22.70 | 2019 | |
| Shockwave Medical, INC | $21.38 | 2021 | |
| Infobionic, INC | $18.99 | 2020 | |
| Csl Behring | $16.63 | 2019 | |
| Gilead Sciences, INC. | $13.73 | 2019 | |
| Cardiva Medical, INC. | $13.53 | 2019 | |
| Lundbeck LLC | $13.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vijay Haryani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.